Predictors of suboptimal surgical cytoreduction in women with advanced epithelial ovarian cancer treated with initial chemotherapy
- 1 July 2008
- journal article
- research article
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 18 (4) , 629-636
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Initial chemotherapy followed by surgical cytoreduction for the treatment of stage III/IV epithelial ovarian cancerAmerican Journal of Obstetrics and Gynecology, 2006
- Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approachGynecologic Oncology, 2004
- Preoperative predictors of suboptimal primary surgical cytoreduction in women with clinical evidence of advanced primary epithelial ovarian cancerInternational Journal of Gynecological Cancer, 2004
- Neoadjuvant chemotherapy for the management of ovarian cancerBest Practice & Research Clinical Obstetrics & Gynaecology, 2002
- Preoperative CA 125 levels: an independent prognostic factor for epithelial ovarian cancerObstetrics & Gynecology, 2002
- Survival Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma During the Platinum Era: A Meta-AnalysisJournal of Clinical Oncology, 2002
- Neoadjuvant chemotherapy or primary surgery in advanced epithelial ovarian carcinomaInternational Journal of Gynecological Cancer, 2001
- Neoadjuvant chemotherapy followed by tumor debulking prolongs survival for patients with poor prognosis in International Federation of Gynecology and Obstetrics Stage IIIC ovarian carcinomaCancer, 2001
- A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomographyCancer, 2000
- The Ability of Preoperative Serum CA-125 to Predict Optimal Primary Tumor Cytoreduction in Stage III Epithelial Ovarian CarcinomaGynecologic Oncology, 2000